Latest News for: rapt

Edit

‘Back on zero’: Power forward rapt to be top AFLW pick, but work begins now

Sydney Morning Herald 15 Dec 2025
Richmond have pounced on West Australian key forward Olivia Wolmarans with the prized No.1 pick in the AFLW draft ....
Edit

‘I’m rapt!’: meatball chants but no mania as New Zealand assembles for first Ikea store

The Observer 04 Dec 2025
I’ve been waiting 25 years for this,” says Annie Sattler ... She was joined by hundreds of shoppers queueing on Thursday morning to mark the end of the national waiting game ... View image in fullscreen ... Photograph ... Photograph ... But they’re here! I’m rapt!” ... .
Edit

Management Change/Compensation (Form 8-K) (Rapt Therapeutics Inc)

Public Technologies 28 Nov 2025
). Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On November 24, 2025, RAPT Therapeutics, Inc ... In exchange for Dr ... Rapt Therapeutics Inc.
Edit

HMCI and Rapt.ai Announce Deployment of NVIDIA GB10 Systems to Power the Rancho Cordova AI ...

Enid News & Eagle 19 Nov 2025
Public–private partnership will deliver affordable, scalable AI development to students, startups, and researchers across the Greater Sacramento region ... .
Edit

HMCI and Rapt.ai Announce Deployment of NVIDIA GB10 Systems to Power the Rancho Cordova AI & Robotics Ecosystem

PR Newswire 19 Nov 2025
The initiative is led through strategic collaboration between NVIDIA, HMCI, Rapt.AI, and the City of Rancho Cordova ... Rapt.AI provides workload-aware GPU orchestration and automation that ... SOURCE Rapt.Ai.
Edit

November 2025 Corporate Presentation (Rapt Therapeutics Inc)

Public Technologies 10 Nov 2025
RAPT Therapeutics is Developing Transformative Therapies for High-Value Inflammatory Diseases ... RAPT Phase 2b FA trial initiated; data expected 1H 2027 ... RAPT Therapeutics Pipeline ... Rapt Therapeutics Inc.
Edit

RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights

Nasdaq Globe Newswire 06 Nov 2025
- Initiated prestIgE Phase 2b trial of ozureprubart in food allergy ... .
Edit

RAPT Therapeutics Reports Third Quarter 2025 Financial Results and Recent Highlights (Form 8-K) (Rapt Therapeutics Inc)

Public Technologies 06 Nov 2025
RAPT) ("RAPT" or the "Company"), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing novel therapies for patients ...
Edit

Quarterly Report for Quarter Ending September 30, 2025 (Form 10-Q) (Rapt Therapeutics Inc)

Public Technologies 06 Nov 2025
). Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations ... See "Special Note Regarding Forward-Looking Statements.". Overview ... Both trials were placed on clinical hold by the U.S ... 2025 ... Rapt Therapeutics Inc.
×